Sonography-Guided Transcervical Ablation of Uterine Fibroids (SONATA)

[This study is no longer recruiting.] The SONATA Study is an FDA-approved clinical study designed to establish the safety and effectiveness of a new, investigational device to reduce heavy menstrual bleeding caused by uterine fibroids. The device, called the SONATA System, targets fibroids rather than treatment or removing the entire uterus. If effective, this device will provide an alternative to hysterectomy that is: incision-free, preserves the uterus, does not require general anesthesia and is an outpatient procedure.

Sponsor(s)
Gynesonics, Inc.
Principal Investigator(s)
Cherie Marfori, MD
Request Information
Address

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

5 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.